(Z)-1-Benzyl-5-(4-bromophenyl)-5-hydroxy-4-(2-oxomorpholin-3-ylidene)pyrrolidine-2,3-dione
Kazuyuki Sato
Round 1
Reviewer 1 Report
Comments and Suggestions for Authors
A. N. Maslivets and his group represented the structure of the title compound, which include the synthetic method.
The synthetic procedure is fine, and the structural analysis and the spectrum data are also well organized to show the product. The experimental section of the article is well organized, but I feel that the introduction seems somewhat poor. This affected my review results, especially 'Quality of Presentation'. I think the authors should add a few more references and/or emphasize the importance of the molecular skeleton - morpholine bearing an azole. Overall, I think the manuscript would be accepted and is enough for publication on Molbank. Short comments are below.
1. Please justify the paragraphs after line 66 on page 2.
2. All symbols of J-coupling ‘J’ should be shown in Italic face.
Comments on the Quality of English LanguageThe paper should be checked by native speakers.
Author Response
Dear editors, thank you for your comments. We have made all the changes: We have added a couple of references to compounds with pharmacological activity to emphasize the importance of the molecular skeleton - morpholine bearing an azole.- We have aligned the paragraphs after line 66 on page 2.
- We have Italic face all the J-coupling symbols "J".
